Transcarent Stock

transcarent.aiHealthcare / Healthcare providers & servicesFounded: 2018Funding to Date: $454.37MM

Transcarent is a digital health company that offers a healthcare technology platform striving to simplify and improve healthcare experiences and outcomes for employers and their employees. The company’s mission is to provide high-quality, affordable, and accessible care. Transcarent was founded in 2020 and is headquartered in Denver, CO. Transcarent also has a consumer-facing mobile app, an on-demand care team, and a network of pre-screened healthcare providers with which the company has direct contracts.

Register To Buy and Sell Shares

For more details on financing and valuation for Transcarent, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Transcarent’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Transcarent.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Transcarent investors also invested in these private companies


Management Team

Glen Tullman
Chief Executive Officer
Snezana Mahon
Chief Operating Officer
Stephanie Peng
Chief Financial Officer
Caitlin Fleming
Chief Strategy Officer
Randy Hawkins M.D.
Chief Medical Officer
Janine Gianfredi
Chief Marketing Officer
Zoë Harte
Chief People Officer
Praful Kaul
Chief Technology Officer
Jason Macaleer
Chief Commercial Officer
Rachel Stillman
Chief of Staff

Board Members

David Calone
Jove Equity Partners
Holly Maloney
General Catalyst

Frequently Asked Questions About Transcarent’s Stock

Can you buy Transcarent’s stock?
Transcarent is not publicly traded on NYSE or NASDAQ in the U.S. To buy Transcarent’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Transcarent’s stock?
Yes, you can sell stock of a private company like Transcarent. Forge can help you sell your Transcarent stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Transcarent’s stock price?
Transcarent is a privately held company and therefore does not have a public stock price. However, you may access Transcarent’s private market stock price with Forge Data.
What is Transcarent’s stock ticker symbol?
Transcarent does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Digital health startup Transcarent valued at $2.2 bln after latest funding round
In a series D funding round led by General Catalyst and 7wireVentures, Transcarent raised $126 million.
Health Startup Transcarent Is Raising a $125 Million
Transcarent is looking to raise $125 million, bringing its valuation to $2.1 billion.
Trans healthcare startup Plume lays off dozens of workers
Plume, a US-based telehealth startup focusing on trans healthcare, has reportedly laid off around one-sixth of its workforce. The company raised $24m in a series B funding round last year and offers online healthcare services to transgender patients, a demographic often facing significant healthcare barriers. Despite the layoffs, Plume confirmed it will not scale back its services and plans to expand its fee-for-service offerings.
Updated on: May 23, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.